Avalon GloboCare Corp. (NASDAQ:ALBT – Get Free Report)’s share price traded down 1.8% during mid-day trading on Friday . The stock traded as low as $3.74 and last traded at $3.77. 6,373 shares traded hands during mid-day trading, a decline of 99% from the average session volume of 521,210 shares. The stock had previously closed at $3.84.
Avalon GloboCare Price Performance
The firm’s 50-day moving average price is $4.17 and its 200-day moving average price is $4.11. The company has a market cap of $7.14 million, a price-to-earnings ratio of -0.19 and a beta of 0.16.
Avalon GloboCare (NASDAQ:ALBT – Get Free Report) last announced its earnings results on Tuesday, May 13th. The company reported ($1.43) earnings per share for the quarter.
Avalon GloboCare Company Profile
Avalon GloboCare Corp., together with its subsidiaries, owns and operates commercial real estate properties in the United States and China. The company develops and delivers transformative cellular therapeutics, precision diagnostics, and clinical laboratory services. Its leading candidates are AVA-001, an anti-CD19 CAR-T, which has completed first-in-human clinical trial for relapsed/refractory (R/R) B-cell lymphoblastic leukemia; and AVA-011 that has completed pre-clinical laboratory studies and undergoing IND-enabling process development stage to generate cGMP-grade AVA-011 CAR-T cells.
Featured Articles
- Five stocks we like better than Avalon GloboCare
- Where Do I Find 52-Week Highs and Lows?
- Pfizer’s 7.5% Dividend: Income Haven or House of Cards?
- 3 Fintech Stocks With Good 2021 Prospects
- 3 Trades Members of Congress Are Making Right Now
- What Does a Stock Split Mean?
- TJX Stock Price Stumble Is Your Chance to Pick Up a Bargain
Receive News & Ratings for Avalon GloboCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avalon GloboCare and related companies with MarketBeat.com's FREE daily email newsletter.
